| abstract |
The invention describes CGRP antagonists of the general formula (I) in which A, X, D, E, G, M, Q and R-R have the meanings indicated in claim 1, their tautomers, their isomers, their diastereomers, their enantiomers , their hydrates, their mixtures and their salts, as well as the hydrates of salts, primarily their physiologically compatible salts with inorganic or organic acids, drugs containing these compounds, their use and the method for their preparation. |